维普中文期刊产品整合服务
33篇 您的检索式:期刊名="Diab Comp"
    题名 作者 年代 出处 被引量
1Markers of diabetic nephropathy显示文摘 Sengchia K 1998J Diab Comp1998,12,:1
2Effect of long-term treatment with a new aldose reductase inhibitor,(2S,4S)-6-Fluoro-2',5'-DioXospiro-2-Carboxamide (SNK-860),on peripheral neuropathy in streptozotocin-induced diabetic rats显示文摘Kato N Mizuno K Matsubara A 1994J Diab Comp1994,8,:1
3Prevalence and trends of insulin resistance, impaired fasting glucose, diabetes显示文摘Ioannou G N Bryson C L Boyko E J 2007J Diab Comp2007,21,6:1
4Anemia and the role of erythropoietin in iabe- tes显示文摘Mc Gill JB Bell DS 2006Diabe Comp2006,20,4:1
5Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis显示文摘HOFFMAN W H LOCKAMITH J P BURTON E M 1998J Diab Comp1998,12,:1
6Increased urinary excretion of kappa light chains in diabetic patients显示文摘OHSAWA K TAKAZAKURA 1991J Diab Comp1991,5,23:1
7Myocardial injury with biomarker elevation in diabetic ketoacidosis显示文摘Moller N Foss AC Gravholt CH 2005J Diab Comp2005,19,6:1
8Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial显示文摘Laudadio C Sima AA 1998J Diab Comp1998,12,:1
9Diabetic angiopathy:tralking down the culpuits显示文摘Tooke JE Shore AC Cohen RA 1996J Diab comp1996,,10:1
10Lipid modulation in insulin-dependent diabetes mellitus:effect on microvascular outcomes显示文摘Fried LF Forrest KY Ellis D 2001J Diab Comp2001,15,3:1
11The ponalrestat Study Group:Progression Rates of Diabetic Neuropathy in Placebo Patients in an 18Month Clinical Trial显示文摘Charles L Ander AFS 1998J Diab Comp1998,12,:1
12Clinical investigation of Epalrestat,an Aldose Reductase Inhibitor,on Diabetic Neuropathy in Japan:Multicenter Study显示文摘Nigishi H Nobuo S Yukio S 1996J Diab Comp1996,10,:1
13The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin dependent diabetes mellitus显示文摘Shoji K Shoichi T Mitsuoshimzu 1994J Diab Comp1994,,8:1
14Effect of long-acting somatostatin analogue (sandostatin) on manifest diabetic ketoacidosis显示文摘YUN Y S LEE H C PARK C S 1999Diab Comp1999,13,56:1
15Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice 显示文摘PEI Fei LI Baoyiug ZHANG Zhen 2014J Diab Comp2014,28,5:1
16Relationship of lipid peroxides to diabetic complicaitons 显示文摘Armstrong D Abdella N Salman A 1992J Diab Comp1992,6,1:1
17Markers of diabetic nephropathy显示文摘YeHong C SengChia K 1998J Diab Comp1998,12,:1
18Clinical evaluation of plasma high-decsity lipoprotein subfractions (HDL2, HDL3) in non-insu- lin-dependent diabetics with coronary artery disease 显示文摘Bakogianni MC Kalofoutis CA Skenderi KI Kalofoutis AT 2001J Diab Comp2001,15,5:1
19Increased urinary excretion of kappa light chains in diabetic patients显示文摘OHSAWA K TAKAZAKURA 1991Diab Comp1991,5,23:1
20Effect of the aldose reductase inhibitor Tolrestat on nerve conduction velocity,Na/K ATPase activity,and polyols in red blood cells,sciatic nerve,kidney cortex,and kidney medulla of diabetic rats显示文摘Raccah D Coste T Cameron NE 1998J Diab Comp1998,12,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费